Abstract:Background The Global increase in colonization by multidrug-resistant (MDR) bacteria poses a significant concern. The precise impact of MDR colonization in solid organ transplant recipients (SOTR) remains not well established. Objectives Assess the impact of MDR colonization on SOTR's mortality, infection, or graft-loss. Methods Data Source Data from PROSPERO, OVID Medline, Ovid EMBASE, Wiley Cochrane Library, ProQuest Dissertations, Theses Global, and SCOPUS, were systematically reviewed spanning from inception until March 20, 2023. The study protocol was registered with PROSPERO (CRD42022290011) and followed the PRISMA guidelines. Study Eligibility Criteria, Participants, interventions, and assessment of risk of bias Cohorts and case-control studies that reported on adult SOTR colonized by Methicillin-resistant Staphylococcus-aureus (MRSA), Vancomycin-resistant Enterococci (VRE), Extended-spectrum beta-lactamase (ESBL) or carbapenem-resistant Enterobacteriaceae (CRE), or MDR-Pseudomonas, and compared to non-colonized, were included Two reviewers assessed eligibility, conducted risk of bias evaluation using the Newcastle-Ottawa scale, and rated certainty of evidence using the GRADE approach. Methods of data synthesis We employed RevMan for a meta-analysis using random-effects models to compute pooled odds-ratios (OR) and 95% confidence-intervals (CI). Statistical heterogeneity was determined using the I 2 statistic. Results 15,202 SOTR (33 cohort, 6 case-control studies) were included, where Liver transplant and VRE colonization (25 and 14 studies) were predominant. MDR colonization significantly increased post-transplant one-year mortality (OR= 2.35, 95%CI 1.63-3.38) and mixed-infections (OR=10.74, 95%CI 7.56-12.26) across transplant types (p<0.001 and I 2 = 58%), but no detected impact on graft-loss (p=0.41, I 2 = 0%). Subgroup analysis indicated a higher association between CRE or ESBL colonization with outcomes (CRE: death OR=3.94, mixed-infections OR=24.8; ESBL: mixed-infections OR=10.3, no mortality data) compared to MRSA (Death: OR=2.25; Mixed-infection: OR=7.75) or VRE colonization (Death: p=0.20, Mixed-infections: OR=5.71). Conclusions MDR colonization in SOTR, particularly CRE, is associated with increased mortality. Despite the low certainty of evidence, actions for preventing MDR colonization in transplant candidates are warranted.

Carbapenem-resistant Enterobacterales in Solid Organ Transplant Recipients

Analysis of Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae Infection and Its Effect on the Outcome of Early Infection after Kidney Transplantation

Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections among Solid Organ Transplant Recipients

The Impact of Colonization by Multi Drug Resistant Bacteria on Graft Survival, Risk of Infection, and Mortality in Recipients of Solid Organ Transplant: Systematic Review and Meta-analysis

An Emerging Issue: Carbapenem-Resistant Enterobacteriaceae in Solid-Organ Transplantation.

Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic review

Risk Factors and Outcomes of Carbapenem-Resistant Enterobacteriaceae Infection After Liver Transplantation: A Retrospective Study in a Chinese Population

Long‐term outcomes after COVID‐19 infection in transplant recipients

The Burden and Impact of Early Post-Transplant Multidrug-resistant Organism Detection Among Renal Transplant Recipients, 2005-2021

Clinical Impact of Community-Acquired Respiratory Viruses in Patients With Solid Organ Transplants

Assessing the quality of antimicrobial prescribing in solid organ transplant recipients: a new frontier in antimicrobial stewardship

The burden of COVID-19 mortality among solid organ transplant recipients in the United States

Clinical features of multidrug-resistant organism infections in early postoperative solid organ transplantation in a single center

Clinical impact of vancomycin-resistant enterococci colonization in nonliver solid organ transplantation and its implications for infection control strategies: A single-center, 10-year retrospective study

Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia

Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study

Postoperative Care and Outcomes in Solid Organ Transplant Patients undergoing Lower Extremity Fracture Treatment

Impact of solid organ transplant status on outcomes of hospitalized patients with COVID‐19 infection

Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections

The Relative Risk of COVID-19 in Solid Organ Transplant Recipients Over Waves of the Pandemic